Isis Appoints Oncology Specialist

Healthcare market research company Isis Research, recently acquired by Synovate, has appointed Debbie Corning to the role of Director of Oncology Syndicated Services, based in Princeton, USA. She will oversees all facets of Isis Research's oncology audits.

Corning has extensive client and agency side experience, including more than 12 years at IMS and spells at Wyeth, Johnson & Johnson, Bristol-Myers Squibb, and most recently Schering AG/Berlex Labs, where she was Director of Oncology Global Market Research. As well as primary research, secondary data, and forecasting she has been involved in a variety of therapeutic areas including Women's Health, CNS, and exclusively in Oncology over the last 4 years. She has also served for 5 years as an officer of PBIRG in the positions of Vice President, Business Research and Vice President, Primary Research.

Isis will rebrand as Synovate Healthcare in the second quarter of 2004.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

• All news